FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1996875331> ?p ?o ?g. }

• W1996875331 endingPage "1009" @default.
• W1996875331 startingPage "1004" @default.
• W1996875331 abstract "Background. Recently, high pretreatment platelet counts and low pretreatment hemoglobin levels were found to be negative prognostic factors in patients with ovarian cancer. Interleukin-6 (IL-6) is a multifunctional cytokine with a diversity of functions leading to the induction of C-reactive protein (CRP), increased platelet counts, and low hemoglobin levels. Different epithelial ovarian cancer cell lines are found to produce varying amounts of IL-6. In this study, a possible relationship between IL-6 levels in cystic fluids of benign and malignant ovarian tumors and pretreatment serum CRP, platelet counts, and hemoglobin levels was evaluated. Methods. A bioassay and enzyme-linked immunosor-bent assay (ELISA) were performed to determine the IL-6 levels in cystic fluids and serum from 42 patients with benign and malignant ovarian tumors. Results. The median IL-6 level was higher in cystic fluids of malignant tumors (n = 21) when compared with cystic fluids of benign tumors (n = 21) (P < 0.01 for bioassay and ELISA). Serum IL-6 levels in patients with malignant tumors were not significantly higher compared with IL-6 levels in patients with benign tumors, whereas CRP levels were higher in patients with malignant tumors (P < 0.01). Cystic fluid IL-6 levels were related to serum CRP levels (r = 0.60, P < 0.01 [bioassay]; r = 0.62, P < 0.01 [ELISA]), platelet counts (r = 0.60, P < 0.01 [bioassay]; r = 0.41, P < 0.01 [ELISA]), and were related inversely to hemoglobin levels (r = −0.57, P < 0.01 [bioassay]; r = 0.54, P < 0.01 [ELISA]). Conclusions. IL-6 levels are higher in cystic fluids of malignant ovarian tumors compared with benign tumors. The relationship of cystic fluid IL-6 levels with CRP, platelet counts, and hemoglobin levels suggests a possible causative role of tumor-derived IL-6 in the appearance of general side effects of ovarian cancer, which recently, have been recognized as prognostic factors. Cancer 1995;75:1004-9." @default.
• W1996875331 created "2016-06-24" @default.
• W1996875331 creator A5003131962 @default.
• W1996875331 creator A5011432801 @default.
• W1996875331 creator A5016301942 @default.
• W1996875331 creator A5039548249 @default.
• W1996875331 creator A5049116732 @default.
• W1996875331 creator A5066701459 @default.
• W1996875331 creator A5068663636 @default.
• W1996875331 creator A5072665003 @default.
• W1996875331 date "1995-02-15" @default.
• W1996875331 modified "2023-10-17" @default.
• W1996875331 title "Higher levels of interleukin-6 in cystic fluids from patients with malignant versus benign ovarian tumors correlate with decreased hemoglobin levels and increased platelet counts" @default.
• W1996875331 cites W1499666737 @default.
• W1996875331 cites W1597952938 @default.
• W1996875331 cites W1632068222 @default.
• W1996875331 cites W1966948292 @default.
• W1996875331 cites W1970128221 @default.
• W1996875331 cites W1970789341 @default.
• W1996875331 cites W1975122645 @default.
• W1996875331 cites W2003687771 @default.
• W1996875331 cites W2007000374 @default.
• W1996875331 cites W2008577129 @default.
• W1996875331 cites W2012265204 @default.
• W1996875331 cites W2023257828 @default.
• W1996875331 cites W2055019214 @default.
• W1996875331 cites W2057393115 @default.
• W1996875331 cites W2085451664 @default.
• W1996875331 cites W2088434784 @default.
• W1996875331 cites W2129344241 @default.
• W1996875331 cites W2138040687 @default.
• W1996875331 cites W2153667962 @default.
• W1996875331 cites W2227161527 @default.
• W1996875331 cites W2239990264 @default.
• W1996875331 cites W2265969331 @default.
• W1996875331 cites W61815858 @default.
• W1996875331 doi "https://doi.org/10.1002/1097-0142(19950215)75:4<1004::aid-cncr2820750416>3.0.co;2-g" @default.
• W1996875331 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7842401" @default.
• W1996875331 hasPublicationYear "1995" @default.
• W1996875331 type Work @default.
• W1996875331 sameAs 1996875331 @default.
• W1996875331 citedByCount "45" @default.
• W1996875331 countsByYear W19968753312012 @default.
• W1996875331 countsByYear W19968753312013 @default.
• W1996875331 countsByYear W19968753312014 @default.
• W1996875331 countsByYear W19968753312015 @default.
• W1996875331 countsByYear W19968753312016 @default.
• W1996875331 countsByYear W19968753312017 @default.
• W1996875331 countsByYear W19968753312018 @default.
• W1996875331 countsByYear W19968753312020 @default.
• W1996875331 countsByYear W19968753312021 @default.
• W1996875331 countsByYear W19968753312022 @default.
• W1996875331 crossrefType "journal-article" @default.
• W1996875331 hasAuthorship W1996875331A5003131962 @default.
• W1996875331 hasAuthorship W1996875331A5011432801 @default.
• W1996875331 hasAuthorship W1996875331A5016301942 @default.
• W1996875331 hasAuthorship W1996875331A5039548249 @default.
• W1996875331 hasAuthorship W1996875331A5049116732 @default.
• W1996875331 hasAuthorship W1996875331A5066701459 @default.
• W1996875331 hasAuthorship W1996875331A5068663636 @default.
• W1996875331 hasAuthorship W1996875331A5072665003 @default.
• W1996875331 hasConcept C104488531 @default.
• W1996875331 hasConcept C121608353 @default.
• W1996875331 hasConcept C126322002 @default.
• W1996875331 hasConcept C134018914 @default.
• W1996875331 hasConcept C142724271 @default.
• W1996875331 hasConcept C2778690821 @default.
• W1996875331 hasConcept C2778917026 @default.
• W1996875331 hasConcept C2780427987 @default.
• W1996875331 hasConcept C54355233 @default.
• W1996875331 hasConcept C71924100 @default.
• W1996875331 hasConcept C86803240 @default.
• W1996875331 hasConcept C89560881 @default.
• W1996875331 hasConcept C90924648 @default.
• W1996875331 hasConceptScore W1996875331C104488531 @default.
• W1996875331 hasConceptScore W1996875331C121608353 @default.
• W1996875331 hasConceptScore W1996875331C126322002 @default.
• W1996875331 hasConceptScore W1996875331C134018914 @default.
• W1996875331 hasConceptScore W1996875331C142724271 @default.
• W1996875331 hasConceptScore W1996875331C2778690821 @default.
• W1996875331 hasConceptScore W1996875331C2778917026 @default.
• W1996875331 hasConceptScore W1996875331C2780427987 @default.
• W1996875331 hasConceptScore W1996875331C54355233 @default.
• W1996875331 hasConceptScore W1996875331C71924100 @default.
• W1996875331 hasConceptScore W1996875331C86803240 @default.
• W1996875331 hasConceptScore W1996875331C89560881 @default.
• W1996875331 hasConceptScore W1996875331C90924648 @default.
• W1996875331 hasIssue "4" @default.
• W1996875331 hasLocation W19968753311 @default.
• W1996875331 hasLocation W19968753312 @default.
• W1996875331 hasOpenAccess W1996875331 @default.
• W1996875331 hasPrimaryLocation W19968753311 @default.
• W1996875331 hasRelatedWork W1966504330 @default.
• W1996875331 hasRelatedWork W1974041167 @default.
• W1996875331 hasRelatedWork W1979139803 @default.
• W1996875331 hasRelatedWork W2027703819 @default.
• W1996875331 hasRelatedWork W2034985166 @default.
• W1996875331 hasRelatedWork W2037631372 @default.

• next